Bloomberg Businessweek Podcast: Using AI Digital Twins for Drug Testing

Dr. Charles Fisher, CEO of Unlearn AI, discusses creating digital clones by using artificial intelligence for use in clinical drug trials. He explains how a medical patient’s data can be used to make a “digital twin” which can help speed up the testing of drugs. Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.

Enter your email address to download paper.

Click the link to begin download.
Oops! Something went wrong while submitting the form.
Blog

AD/PD 2021: Unlearn will present novel, AI-driven approaches to enabling smaller, more efficient Alzheimer’s clinical trials

Press

How Digital Twin Technology is Disrupting Healthcare

Press

Next-gen digital health innovation in clinical trials

The Rock Health team reflects on the evolution of digital in clinical trials, discuss the current state, and explore the opportunity to further transform drug discovery.
The use of digital twins in the healthcare industry is revolutionizing clinical processes.
Join us at The 15th​ International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders, March 9 - 14, 2021.